Form 8-K - Current report:
SEC Accession No. 0001104659-23-023512
Filing Date
2023-02-21
Accepted
2023-02-21 07:05:36
Documents
14
Period of Report
2023-02-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm237305d1_8k.htm   iXBRL 8-K 30790
2 EXHIBIT 99.1 tm237305d1_ex99-1.htm EX-99.1 22265
6 GRAPHIC tm237305d1_ex99-1img001.jpg GRAPHIC 2647
  Complete submission text file 0001104659-23-023512.txt   238756

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA asrt-20230221.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE asrt-20230221_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asrt-20230221_pre.xml EX-101.PRE 22599
8 EXTRACTED XBRL INSTANCE DOCUMENT tm237305d1_8k_htm.xml XML 3606
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39294 | Film No.: 23645230
SIC: 2834 Pharmaceutical Preparations